Pharvaris (PHVS)
Develops oral deucrictibant formulations to treat and prevent hereditary angioedema attacks.
$35.20
After hours+0.01 (+0.03%)
At close$35.19(−2.30%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
estimated · in 50 days
EPS estimate
−$0.82
Revenue estimate
$2.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Apr '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported−$0.66−$0.89−$0.94−$0.70−$0.85−$0.70−$0.81Pending
Estimate−$0.75−$0.80−$0.87−$0.78−$0.71−$0.82−$0.75−$0.82
Surprise+11.5%−11.2%−8.0%+10.3%−18.3%+14.8%−8.5%—
RevenueReportedEstimate
Apr '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported———————Pending
Estimate———————$2.3M
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.62 | — | — |
| Sep 2027 | −$0.74 | — | — |
| Jun 2027 | −$0.77 | — | — |
| Mar 2027 | −$0.73 | — | — |
| Dec 2026 | −$0.77 | — | — |
| Nov 2026 | −$0.82 | — | — |
| Aug 2026 | −$0.75 | −$0.81 | −8.5% |
| May 2026 | −$0.82 | −$0.70 | +14.8% |
| Apr 2026 | −$0.71 | −$0.85 | −18.3% |
| Nov 2025 | −$0.78 | −$0.70 | +10.3% |
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Apr 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jul 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| May 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.62 | — | — | $19.6M | — | — | — |
| Sep 2027 | −$0.74 | — | — | $6.4M | — | — | — |
| Jun 2027 | −$0.77 | — | — | $2.3M | — | — | — |
| Mar 2027 | −$0.73 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.77 | — | — | $6.5M | — | — | — |
| Nov 11, 2026 | −$0.82 | — | — | $2.3M | — | — | — |
| Aug 12, 2026 | −$0.75 | −$0.81 | −8.5% | — | — | — | +5.9% |
| May 12, 2026 | −$0.82 | −$0.70 | +14.8% | — | — | — | +4.3% |
| Apr 2, 2026 | −$0.71 | −$0.85 | −18.3% | — | — | — | −0.7% |
| Nov 12, 2025 | −$0.78 | −$0.70 | +10.3% | — | — | — | +7.0% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Apr 7, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 8, 2024 | |||||||
| Apr 3, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 8, 2023 | |||||||
| Apr 5, 2023 | |||||||
| Dec 8, 2022 | |||||||
| Sep 12, 2022 | |||||||
| Jul 1, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 29, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Jul 30, 2021 | |||||||
| Apr 30, 2021 | |||||||
| May 26, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |